Characteristics of study patients
| PJP free patients (n = 17) | PJP patients (n = 23) | |
|---|---|---|
| PJP, Pneumocystis jerovici pneumonia; IVDU, intravenous drug use. | ||
| *p<0.05, PJP v PJP free patients. | ||
| Mean (SE) age (years) | 33 (3) | 35 (4) |
| Antiretroviral treatment | 7 (41%) | 8 (35%) |
| PJP prophylaxis | 7 (39%) | 4 (17%) |
| Mean (SE) CD4 cells/mm3 | 174 (23) | 73 (15)* |
| HIV transmission | ||
| Homosexual | 11 (65%) | 19 (82%) |
| IVDU | 2 (12%) | 2 (9%) |
| Others | 4 (24%) | 2 (9%) |